Details for New Drug Application (NDA): 070050
✉ Email this page to a colleague
NDA 070050 describes VALNAC, which is a drug marketed by Actavis Mid Atlantic and is included in one NDA. Additional details are available on the VALNAC profile page.
The generic ingredient in VALNAC is betamethasone valerate. There are sixty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in VALNAC is betamethasone valerate. There are sixty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 070050
| Tradename: | VALNAC |
| Applicant: | Actavis Mid Atlantic |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070050
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Oct 10, 1984 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
